» Articles » PMID: 20506447

Typologies of Cannabis Users and Associated Characteristics Relevant for Public Health: a Latent Class Analysis of Data from a Nationally Representative Canadian Adult Survey

Overview
Specialty Psychiatry
Date 2010 May 28
PMID 20506447
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Cannabis is the most prevalently used illicit drug in Canada. Current policy consists primarily of universal use prohibition rather than interventions targeting specific risks and harms relevant for public health. This study aimed to identify distinct groups of cannabis users based on defined use characteristics in the Canadian population, and examine the emerging groups' associations with differential risk and harm outcomes. One thousand three hundred and three current (i.e. use in the past three months) cannabis users, based on data from the representative cross-sectional 2004 Canadian Addiction Survey (N = 13,909), were statistically assessed by a 'latent class analysis' (LCA). Emerging classes were examined for differential associations with socio-demographic, health and behavioral indicators on the basis of chi-square and analysis of variance techniques. Four distinct classes based on use patterns were identified. The class featuring earliest onset and highest frequency of use [22% of cannabis user sample or 2.2% (95% confidence interval (CI) = 1.8-2.7%) of the Canadian adult population] was disproportionately linked to key harms, including other illicit drug use, health problems, cannabis use and driving, and cannabis use problems. A public health framework for cannabis use is needed in Canada, meaningfully targeting effective interventions towards the minority of users experiencing elevated levels of risks and harms.

Citing Articles

Profiles of cannabis users and impact on cannabis cessation.

MacQuarrie A, Brunelle C PLoS One. 2024; 19(6):e0305088.

PMID: 38861510 PMC: 11166302. DOI: 10.1371/journal.pone.0305088.


Differentiating people who use cannabis heavily through latent class analysis.

Alvarez-Roldan A, Garcia-Munoz T, Gamella J, Parra I, Duaso M Subst Abuse Treat Prev Policy. 2023; 18(1):31.

PMID: 37264404 PMC: 10236746. DOI: 10.1186/s13011-023-00540-3.


Typology of Adolescents Exposed to Non-medical Cannabis Marketing and Associations with Consumption Patterns.

Trangenstein P, Gora Combs K, Whitehill J, Jenkins M, Jernigan D, Moreno M Prev Sci. 2022; 23(7):1276-1286.

PMID: 35622192 PMC: 10326727. DOI: 10.1007/s11121-022-01378-0.


Early, Chronic, and Acute Cannabis Exposure and Their Relationship With Cognitive and Behavioral Harms.

Lopez-Pelayo H, Campeny E, Oliveras C, Rehm J, Manthey J, Gual A Front Psychiatry. 2021; 12:643556.

PMID: 34434125 PMC: 8381725. DOI: 10.3389/fpsyt.2021.643556.


Why do Americans use marijuana?.

Kurtzman E, Young-Wolff K Drug Alcohol Depend. 2021; 226:108880.

PMID: 34256265 PMC: 8355057. DOI: 10.1016/j.drugalcdep.2021.108880.


References
1.
Nutt D, King L, Saulsbury W, Blakemore C . Development of a rational scale to assess the harm of drugs of potential misuse. Lancet. 2007; 369(9566):1047-53. DOI: 10.1016/S0140-6736(07)60464-4. View

2.
Copeland J, Swift W, Rees V . Clinical profile of participants in a brief intervention program for cannabis use disorder. J Subst Abuse Treat. 2001; 20(1):45-52. DOI: 10.1016/s0740-5472(00)00148-3. View

3.
Kaye S, Darke S . A comparison of the harms associated with the injection of heroin and amphetamines. Drug Alcohol Depend. 2000; 58(1-2):189-95. DOI: 10.1016/s0376-8716(99)00102-7. View

4.
Ounpuu S, Krueger P, Vermeulen M, Chambers L . Using the U.S. Behavior Risk Factor Surveillance System's health related quality of life survey tool in a Canadian city. Can J Public Health. 2000; 91(1):67-72. PMC: 6980029. View

5.
Asbridge M, Poulin C, Donato A . Motor vehicle collision risk and driving under the influence of cannabis: evidence from adolescents in Atlantic Canada. Accid Anal Prev. 2005; 37(6):1025-34. DOI: 10.1016/j.aap.2005.05.006. View